rolipram has been researched along with Hyperventilation in 1 studies
Hyperventilation: A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billah, MM | 1 |
| Cooper, N | 1 |
| Minnicozzi, M | 1 |
| Warneck, J | 1 |
| Wang, P | 1 |
| Hey, JA | 1 |
| Kreutner, W | 1 |
| Rizzo, CA | 1 |
| Smith, SR | 1 |
| Young, S | 1 |
| Chapman, RW | 1 |
| Dyke, H | 1 |
| Shih, NY | 1 |
| Piwinski, JJ | 1 |
| Cuss, FM | 1 |
| Montana, J | 1 |
| Ganguly, AK | 1 |
| Egan, RW | 1 |
1 trial available for rolipram and Hyperventilation
| Article | Year |
|---|---|
Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adolescent; Adult; Aged; Animals; Anti-Asthmatic Agents; Bindin | 2002 |